发明名称 PROSTAGLANDIN ANALOGUES
摘要 <p>Prostaglandin E1 analogues of the general formula: <IMAGE> IV [wherein Y represents ethylene or trans-virylene, Z represents ethylene or trans-vinylene, R1 represents a hydrogen atom, an alkyl group containing 1 to 12 carbon atoms, an aralkyl group containing from 7 to 12 carbon atoms, a cycloalkyl group containing from 4 to 7 carbon atoms and unsubstituted or substituted by at least one alkyl group containing from 1 to 6 carbon atoms, a phenyl group unsubstituted or substituted by at least one chlorine atom, trifluoromethyl group, alkyl group containing from 1 to 4 carbon atoms or phenyl group, a-CmH2mCOOR5 group (wherein m represents an integer of from 1 to 12 and R5 represents a hydrogen atom or an alkyl group containing from 1 to 4 carbon atoms ), a -CnH2nOR6 group (wherein R6 represents a hydrogen atom or an alkyl group containing from 1 to 4 carbon atoms and n represents an integer of from 2 to 12), or a <IMAGE> group (wherein R7 and R8 each represent a hydrogen atom or an alkyl group containing from 1 to 4 carbon atoms and n is as hereinbefore defined), R2 represents a hydrogen atom or a methyl or ethyl group, R3 represents a single bond or an alkylene group containing from 1 to 4 carbon atoms, R4 represents a hydrogen atom, an alkyl group containing from 1 to 8 carbon atoms, a cycloalkyl group containing from 4 to 7 carbon atoms and unsubstituted or substituted by at least one alkyl group containing from 1 to 8 carbon atoms, or represents a phenyl or phenoxy group unsubstituted or substituted by at least one chlorine atom, trifuloromethyl group or alkyl group containing from 1 to 3 carbon atoms, and the wavy line attached to the C-11 and C-15 carbon atoms represents alpha - or beta -configuration or mixtures thereof] and cyclodextrin clathrates thereof, and, when R1 represents a hydrogen atom or a group CmH2mCOOR5 in which R5 represents a hydrogen atom, non-toxic salts thereof and, when R1 represents a group <IMAGE> non-toxic acid addition salts thereof, are new compounds and possess characteristic prostaglandin-like properties.</p>
申请公布号 IE781857(L) 申请公布日期 1979.03.16
申请号 IE19780001857 申请日期 1978.09.14
申请人 ONO PHARMACEUTICAL CO. LTD. 发明人
分类号 C08L5/00;A61K31/20;A61K31/215;A61K31/557;A61K31/5575;A61P43/00;C07C67/00;C07C401/00;C07C405/00;C07D307/935;C07D307/937;C07F1/02;(IPC1-7):C07C177/00;C08B37/16;C07D309/12;C07D307/20 主分类号 C08L5/00
代理机构 代理人
主权项
地址